RPL17 and lung cancer: However, limitation included in the manuscript is that the mechanism of PD-1/PD-L1 inhibitor chemotherapy combined with Lung Cancer Fang No. 1 decreases the levels of CYFRA21-1, CA125, and VGEF which remains unknown, which will be investigated in further study.